Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314

Clinical trial NCT04871646 · UNKNOWN

Trial details

NCT number: NCT04871646
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

COVID-19 Pneumonia

Start date: 2021-06-30
Primary completion: 2022-03-01
Enrollment: 586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.